ABSTRACT: Many infectious disease agents affect salmonids early in life, long before the immune system of the flsh is able to mount an efficient, protective response. This study wasundertaken to determine if protective antibodies could be transferred to salmonid eggs and embryos by injecting the antibodies into female broodstock salmon prior to spawning. Resistance to Vibrio anguillarum (Va) was used as the model for this system because it is known that resistance to vibriosis is antibody-mediated. Antibodies raised against Va in rabbits were injected into female coho salmon Oncorhynchus kisutch before spawning and were detectable in the eggs by unmunoassays. Fry from the injected broodstock were also challenged with Va following absorption of their yolk sac, but were not protected against Va. Contents of eggs from all broodstock (including saline-injected controls) were injected into naive coho fry, which were then challenged with live Va. Egg material from broodstock injected with rabbit antiVa antibodies conferred protection against Va, In contrast, egg material from broodstock injected with saline did not. The results suggest that vertical transfer of mammalian antibodies can occur in salmonids; however, any conferred protection is not maintained for long after the yolk sac is absorbed. The findings described demonstrate a potentially useful new approach for passively immunizing large numbers of yolk sac larval salmonids against certain pathogens.
INTRODUCTION
Many pathogens cause disease in juvenile salmonids. Infectious haematopoietic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV), as examples, normally cause their greatest losses in salmonids during the early fry stages. Frequently these pathogens infect the young salmonids before the fish immune system is sufficiently mature to offer any significant specific protection. Indeed, some infectious agents such as IPNV (Wolf et al. 1963 ) and the kidney disease bacterium Renibacterium salmoninarum (Eve- 'Present address: National Research Council of Canada, Institute for Marlne Blosciences, 141 1 Oxford Street, Halifax. Nova Scotia, Canada B3H 321. E-mail: laura.brown@nrc.ca lyn et al. 1984) can occur in eggs, and thus salmonids can be exposed to pathogens as early as the embryonic stage. Little is known of the possible mechanisms for protecting young salmonids from these and other pathogens. Furthermore, we do not have complete information concerning protective substances deposited by female salmon in their eggs that are transferable and protective to their offspring. Lysozyme levels are very high in freshly spawned salmonid eggs and the anti-microbial activity of the enzyme probably explains why only a limited number of bacterial pathogens are normally capable of vertical transmission (Yousif et al. 1994a) . Presumably, the lysozyme also confers some protection in salrnonid fry. Yousif et al. (1994b) also demonstrated the presence of lectin with antibacterial activity within freshly spawned sal-mon eggs. Other research has demonstrated the vertical transfer of immunoglobulin-like proteins in teleost species (Bly et a1 1986 , Shors & Winston 1989 , Mor & Avtalion 1990 , Hayman & Lobb 1993 . Passive transfer of protection (rather than simply the transfer of immunoglobulin-like proteins) from female broodstock salmon to their progeny has been suggested in some teleost species. Kawahara et al. (1993) have indicated that protection of charr Salvelinus leucomaenis against Aeromonas salmonicida was passively transferred from female broodstock that were actively immunized against the pathogen, and transfer of protective immunity has been demonstrated in tilapia Oreochromis aureus (Sin et al. 1994 ) and in rainbow trout Oncorhynchus mykiss (Oshima et al. 1996) . In contrast, iillehaug et al. (1996) vaccinated brood female Atlantic salmon Salmo salar against Yersinia ruckeri and, although they were able to detect specific agglutinating antibodies within the resulting eggs and posthatch fry, the authors found these low levels of salmonid antibodies were unable to protect the offspring against yersiniosis upon challenge.
The goals of this study were to determine whether female salmonids are capable of depositing externally derived (mammalian) antibodies in their eggs, and whether such antibodies would confer protection against an appropriate challenge on the fry hatching from such eggs. Antibodies raised against the bacterial fish pathogen Vibrio anguillarum (Va) were used. V. anguillarum is not normally an early life-stage pathogen of salmonids, but it is recognized that protection against Va in salmonids and other teleosts is mediated by humoral antibodies (Harrell et al. 1975 , Viele et al. 1980 , Groberg 1982 , Aoki et al. 1984 . The passive transfer of protective anti-Vibrio ordalii antibodies, both salmonid and mammalian was demonstrated by Velji et al. (1991) , and thus the Vibrio model appeared suitable for our purposes.
Our experimental approach was to examine whether injecting female salmon with anti-Va antisera shortly before spawning resulted in the deposition of protective anti-Va antibodies in their eggs, and whether any protection was transferred to their progeny. Mammalian antibodies were used because mammals are more efficient antibody producers than salmonids and because large quantities of antibodies might be needed if the procedure proved sufficiently efficacious to warrant further examination.
MATERIALS AND METHODS

Bacteria.
Vibrio anguillarum (Va; Pacific Biological Station strain R20, serovar 01) were grown at room temperature in aerated Brain Heart Infusion broth (Difco, USA) for 24 h. Following incubation, formalin 10.5 % (vlv)] was added to the culture. The culture flask wds left at room temperature for at least 1 h, to ensure complete killing of all bacteria. The cell suspension in broth was adjusted to ca 2 X 108 cells ml-l, corresponding to an absorbance of 5.0 at 420 nm. This suspension was used for all immunizations and for all subsequent serum and egg adsorption steps.
Renibacterium salmoninarum (Rs) strain 384 (Pacific Biological Station, Nanaimo, BC, Canada) was grown, harvested, and formalin-killed as described elsewhere (Brown et al. 1996) . Rs cells were used for serum and egg adsorption steps.
Antibodies. Three New Zealand white rabbits were given a subcutaneous injection (0.5 m1 kg-' animal weight) of the Va suspension diluted 1:l with Freund's incomplete adjuvant. Four weeks later, the animals were give~l a second identical injection. Two weeks later, the rabbits were given a third injection of the bacterial suspension (0.5 m1 kg-') without adjuvant. Ten days following the third injection the animals were terminally bled. The resulting sera were kept at -80°C.
The rabbit immunoglobulins were concentrated by precipitation with saturated ammonium sulfate (Harlow & Lane 1988) as follows: sera from the 3 rabbits were pooled and centrifuged at 1700 X g for 45 min to remove any debris. The supernatants were added to equal volumes of saturated ammonium sulfate and stirred overnight at 4OC. The precipitates were then centrifuged at 1700 X g for 45 min, and the pellets were resuspended in phosphate buffered saline (PBS: 140 mM NaC1,8 mM KpHPO,, 2.5 mM KH2P0,), at 1/10 of the starting volumes, after which they were dialysed against 3 changes of PBS overnight at 4°C. Protein concentration was determined (Lowry et al. 1951 ) using a commercially available test kit (Sigma, USA). The protein concentrations were adjusted to 50 mg ml-' with PBS. The concentrated rabbit anti-Va antibodies (RAVA) were examined by polyacrylamide gel electrophoresis (PAGE).
Injection of broodstock. The RAVA preparation was injected (100 mg total protein per fish) into 6 wildcaught, mature female coho salmon Oncorhynchus kisutch, average weight 1.5 kg, that were being held at a Department of Fisheries and Oceans Salmon Enhancement Hatchery, Capilano, North Vancouver, BC, Canada. Six additional fish were injected with sterile saline as controls (1.0 m1 fish l ) . Passive integrated transponder (PIT) tags were inserted into the dorsal musculature of each fish for individual identification. The injection was given 11 to 26 d before spawning.
When ripe, the fish were manually spawned and the eggs collected and transported to the laboratory. Kidney samples were aseptically removed and examined by light microscopy and by culture to determine if Va was present. Samples of milt, for fertilization, were taken from male coho within the same stock as the injected females. Most of the eggs from each female were rinsed in sterile PBS and stored at -80°C.
Extraction of proteins from egg contents. For Western blot and PAGE analysis, proteins were extracted from the contents of the eggs of the injected broodstock following the method by Bade & Stegemann (1984) . Twenty eggs from each fish were thawed and pooled according to treatment group (at least 5 fish per group). Eggs were blotted on sterile filter paper to remove surface liquid, and content were removed aseptically from the eggs with 1 m1 syringes and disposable 25 gauge needles. Pre-cooled (-20°C) isopropyl alcohol was added to the egg contents at a ratio of 1:3 (egg contents:alcohol) and mixed at 4'C for 30 min. The precipitated proteins were allowed to settle for 5 min before discarding the supernatant. This procedure was repeated 3 times with alcohol, and twice with pre-cooled acetone, in order to ensure complete removal of lipids. The final residue was collected in a Buchner funnel by washing with a small amount of acetone and then air-dried. The powder was stirred in PBS for 1 h at room temperature. Insoluble material was removed by centrifugation at 10 000 X g and the PBS-soluble egg extract (EE) stored at 4°C.
Electrophoresis and Western blots of RAVA and egg extracts. RAVA and egg extract proteins were separated by SDS-PAGE (separating gels: 12 % acrylamide, stacking gels: 6 % acrylamide at 150 V for 45 min), under denaturing conditions (with 2-mercaptoethanol) as outlined in Harlow & Lane (1988) . All steps were carried out at room temperature. After electrophoresis, proteins were electrophoretically transferred to a nitrocellulose (NC) membrane using a Mini-Blot apparatus (BioRad Laboratories) at 0.8 mA cm'' for 1 h. After blotting, the unreacted sites on the NC membrane were blocked with 3% (w/v) gelatin in Tris-buffered saline (TBS: 20 mM Tris, 500 mM NaC1, pH 7.5). The NC membrane was incubated with gentle shaking overnight with the primary antibody (goat anti-rabbit IgG, Sigma). Primary antibodies were diluted 1:100 in antibody butfer [TBS containing 1 % (w/v) gelatin]. After washing, the NC membrane was incubated for 3 h with the secondary antibody [a biotinylated monoclonal antibody directed against goat IgG (Sigma)], diluted 1:200 in antibody buffer. A streptavidin-peroxidase solution diluted 1:200 in TBS was added, and the colour developed by adding 3,3'-diaminobenzidine tetrahydrochloride [DAB, 0.06 
Challenge of the progeny of injected broodstock with Vibrio anguillarum. At spawning, about 200 eggs from each fish were fertilized, water-hardened and incubated in flowing water. The eggs from each fish were incubated separately and the progeny from all fish in a given treatment group pooled and then randomly divided into three 40 1 pot tanks (100 fish per group per tank) and acclimated to 13°C. Two weeks after the fry were feeding (i.e. the yolk sac had been completely absorbed and the fry were relying solely on external food sources), they were all subjected to an immersion challenge with live Va cells. Briefly, Va was grown on Tryptic Soy Agar [TSA supplemented with 0.85% (w/v) NaCl] for 48 h at 15°C and the cells were removed aseptically and suspended in peptone-saline [P/S; 0.1 to 0.85 % w/v]. The suspension was adjusted to yield an absorbance of 2.5 at 420 nm. The fish were netted and immersed for 15 min in 2 1 P/S, with aeration, to which had been added enough bacterial suspension to give a final dose of 105 cells ml-'. The fish were returned to their particular tank. After challenge, mortality was monitored for 13 d. Mortality was determined as being due to vibriosis by examining at least 25 % of all carcasses. Kidney samples were aseptically removed and smeared onto glass slides (for Gram staining) and onto NaC1-supplemented TSA plates which were incubated at 15OC for at least 72 h. Results were expressed as the mean cumulative percent mortality based on data from 3 replicate tanks per treatment group plus the standard error. The percent mortality at each time point for each treatment was compared to its appropriate control by means of the log-likelihood ratio or G-test (Sokal & Rohlf 1981) .
Passive transfer of immunity. One hundred eggs were taken from each group of injected broodstock (ca 20 eggs per fish), and the contents were removed aseptically with 1 m1 syringes and disposable 25 gauge needles and then pooled. Egg contents were diluted 1:2, 1:9, or 1:49 in PBS. In addition, aliquots of egg contents (diluted 1:l) were adsorbed with Va or Rs before injection into fry. A heavy Va or Rs suspension (absorbance = 5.0 at 420 nm) was added to samples at a 1 : l ratio. The mixture was incubated at 4°C for 1 h, after which the cells were centrifuged and the pellet discarded. This adsorption step was repeated and the supernatant used for injection. The diluted or adsorbed, and non-adsorbed egg content samples were injected (0.1 m1 per fish) intraperitoneal (i.p.) into naive coho salmon fry (ca 5 to 7 g each). The fish were kept in freshwater and had not been vaccinated against vibriosis. Additional groups of fry were injected with the RAVA (diluted to 1:9 in PBS) originally injected into the broodstock before spawning. Aliquots of the RAVA were also adsorbed with Va or Rs cells, and then injected into groups of fry, as above. Additional groups of fry were injected with sterile saline only (100 p1 per fish), or were not injected (Table 1) . To obviate tank effects and the need for replicate tanks, all injected fish were fin-clipped to distinguish the various treatment groups, 25 fish per group, and then pooled into a single Fig. lB , lanes 1 and 2, but are absent from Group 2 tank. One day (24 h) after injection, the fry were sub-(saline-injected) EE samples (Fig. lB, lane 3) . jected to an immersion challenge with live Va (10' cells ml-' for 15 min) as previously described. Water temperature was maintained at 12°C. Mortality was moniChallenge of progeny of injected broodstock with Va tored for 14 d, and verified as being due to vibriosis.
When the progeny were challenged with live Va cells, there was a small (15% units) but significantly RESULTS higher (p < 0.05) mean cumulative percent mortality after 13 d (Fig. 2) among the progeny of broodstock Evidence of previous Va infection within injected with RAVA (Group l), as compared with that broodstock tissues obtained with progeny derived from the control broodstock (Group 2). There was no evidence of Va within any of the kidney taken from the injected broodstock, as examined by Gram stain and culture on NaC1-supplemented TSA.
Passive transfer of immunity Rabbit antibodies against Va are deposited in egg contents
The dominant bands detected by antiserum against rabbit IgG in RAVA preparations are the ca 55 kDa and 25 kDa proteins characteristic of mammalian immunoglobulin heavy and light chains (Fig. 1A) . These proteins are clearly detected in egg extracts (EE) from Group 1 (RAVA injected broodstock), as seen in Therc was a significani decrease (p < 0.01) in mortality due to vibriosis among fry injected with egg contents derived from RAVA-injected broodstock (Table 1 , treatments 1, 2, and 3) compared with fry injected with similarly diluted egg contents derived from the Group 2 (saline injected) broodstock fish (treatments 6, 7, and 8). There was also a significantly lower mortality experienced by the same fry (treatments 1, 2, and 3) than by the fry injected with saline only (treatment 14), or with fry that were fin-clipped only (no injection; treatment 15). This was most pronounced when the Table 1 . Material injected (i.p.) into coho fry for passive transfer of immunity. Fry were fin-clipped to denote treatment (n = 25 per treatment) and placed in a single tank following a bath challenge with Vibrio anguillarum (Va) . Resulting mortalities (cumulative mortalities) were determined at 14 d. Broodstock group: Group 1 = injected with anti-Va rabbit antibodies (RAVA). Group 2 = injected with saline only. Broodstock injections were given 11 to 26 d before spawning. Asterisk represents significant difference ("p < 0.01 or ' p < 0.05) between mortalities experienced by a treatment group (fry injected with egg material from Group 1 broodstock or with RAVA) and the corresponding control group (fry injected with egg material from Group 2 broodstock, with saline, or not lnlected] egg contents were diluted beyond 1:l in PBS. In fact, 1:9 and 1:49 dilutions of egg contents from Group l broodstock gave significantly (p < 0.05) better protection than the 1 : l dilution (treatments 2 and 3 vs 1).
There was no significant difference in the mortality experienced by fry injected with egg contents from Group 2 (saline injected) and adsorbed with Va (treatment 9) or Rs (treatment 10) compared to fry injected with unadsorbed Group 2 egg contents (treatment 6 ) . In contrast, there was a significant increase (p < 0.01) in mortality among fry injected with egg contents (treatment 4) from Group 1 adsorbed with Va cells, the homologous antigen, compared with that for fry injected with unadsorbed egg contents (treatment 1). There was no corresponding increase in mortality among the fry injected with the same egg contents adsorbed with Rs (treatment 5).
There was a significant decrease (p < 0.01) in mortality among the fry injected with the RAVA originally injected into the broodstock salmon (treatment 11). When this antiserum was adsorbed with homologous antigen (Va cells; treatment 12), there was a significant increase in mortality due to vibriosis; in contrast, when the antiserum was adsorbed with non-homologous antigen (Rs; treatment 13), there was no increase in mortality.
DISCUSSION
The results show mammalian antibodies injected into mature female coho salmon are transferred to their eggs (Fig. 1) . The mammalian antibodies are active and capable of providing specific protection against a challenge with the homologous pathogen ( Table 1) . The passive transfer experiment was performed to demonstrate the functional presence of the antibodies found in the eggs (and assumed to be vertically transferred), and also to mimic the situation that might be expected to occur within developing alevins still in the process of absorbing their yolk sacs. Yolk sacs that contain appropriate protective immunoglobulins may therefore confer protection against pathogens that affect the embryo during early life stages. However, this type of protection apparently does not persist after the yolk has been absorbed, as revealed by the results of the challenge to the progeny of the injected broodstock (Fig. 2) .
In the passive transfer experiment, the highest level of protection against Va was conferred by the highest dilutions tested (1:9 and 1:49) of the egg material containing the rabbit immunoglobulin (see Table 1 ). There are a t least 2 possible explanations for this difference. First, the protective antibodies may not have been able to leach out of the concentrated egg proteins and lipids present in ihe 1:1 dilution rapidly enough to ensure maximum protection of the fry, whereas the more dilute mixture may have freed the clearly adequate amount of protective anti-Va antibodies present (as seen in the results shown in Table 1 ). Second, the fry may have been unduly stressed by an i.p. injection of a concentrated amount of egg protein and lipid, and may have compromised their ability to resist the Va challenge, despite the presence of the anti-Va antibodies. Whether this situation would be repeated in an alevin that was slowly absorbing its yolk sac is unknown. However, if this were the case, survival in alevins containing protective antibodies would still be expected to be considerably better than in alevins lacking the antibody. The data in Table 1 show antibodies in the most concentrated yolk material tested still reduced mortality significantly (from 100 to 40%) on challenge.
The presence of specific mammalian immunoglobulins within the eggs is the most likely explanation for the protective effect seen in the passive transfer experiment. However, the possibility does exist that the RAVA injected into the Group 1 broodstock could have contained protective non-immunoglobulin proteins such as C-reactive or complement proteins that might have contributed to the observed protective effect. Non-specific acute-phase proteins (such as C-reactive proteins) do not persist long in an immunized animal (Mims 1990 ). The adsorption of egg contents with either Va or Rs cells was done in order to demonstrate the specificity of any protection conferred by the egg contents. Therefore, the results of the passive transfer of Va or Rs-adsorbed EE from the rabbit antiseruminjected broodstock suggest a high degree of specificity, normally associated with imrnunoglobulin molecules.
Because of l~mited availability of tanks, we were constrained to challenge the progeny of the injected broodstock at a stage past first-feeding only, rather than during the sac fry stage and at first feeding. Ideally, challenges should have been done at these stages also. The reason for the small (15 % units) but significant increase in mortality due to vibriosis among progeny of fish injected with rabbit anti-Va antiserum compared with progeny of control fish (Fig. 2) is unknown. However, despite the increase in mortality, the advantages that would be conferred by passive immune therapy for the young yolk-sac fry with mammalian antibodies against very early life-stage pathogens that have the potential to kill an entire stock (e.g. IHNV) would certainly outweigh the risk of later small losses due to the mammalian serum proteins.
The quantity of rabbit antibody proteins injected into the female broodstock was approximately the same size as that found in immunized salmonids, and was therefore a reasonable amount for these experiments. The dose of RAVA injected was calculated by extrapolation from previous studies to determine relative volumes of seru.m per fish weight, concentratioi~ of serum protein within an immunized fish, and relative concentration of immunoglobulin to total serum protein (Evelyn 1971 , Groberg et al. 1979 , Ingram & Alexander 1979 , lwama et al. 1986 ). The timing for injecting the brood fish was chosen based on our previous experience with incorporation of antibiotics into salmonid eggs via broodstock injection (Brown et al. 1990 ). The fact that rabbit immunoglobulin proteins were detected in the egg contents of the RAVA-injected fish indicates that this was an appropriate choice; however, this does not preclude the possibility that multiple injections, and/or injections at times earlier in oogenesis, would be as or more effective.
The results of this study indicate passive immunization of pre-spawning female salmon with mammalian antibodies has considerable potential as a means of protecting juvenile salmonids against pathogens that affect the fish at early life-stages, e.g. Flavobacterium psychrophilurn, cause of coldwater disease, or viral pathogens, such as IPNV and IHNV. The protection would, however, be short-term, and probably would not extend beyond the yolk-sac stage. The technique holds promise as a means of preventing vertical transmission of salmonid pathogens. For example, it is conceivable that the vertical transmission of IPNV could be prevented with a pre-spawning injection of anti-IPNV neutralising antibody raised in mammals. Also, it could prove of value in negating the adverse (tolerogenic) effects of molecules such as the Rs p57 molecule that may be depos~ted in eggs of Rs-infected fish (Brown et al. 1996) . Using broodstock salmonids as the vehicle, it may be possible to entrain a wide range of molecules (e.g. molecules of pharmacological interest) into salmonid eggs. The mechanism by which proteins and other molecules [e.g. antibiotics (Brown et al. 1990 )l are taken up by (or excluded from) salmonid eggs is a subject for further research.
